311 related articles for article (PubMed ID: 25798941)
1. The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice.
Venardos K; De Jong KA; Elkamie M; Connor T; McGee SL
PLoS One; 2015; 10(3):e0120934. PubMed ID: 25798941
[TBL] [Abstract][Full Text] [Related]
2. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model.
Liu X; Xu Q; Wang X; Zhao Z; Zhang L; Zhong L; Li L; Kang W; Zhang Y; Ge Z
Pharmacol Res; 2015 Mar; 93():43-51. PubMed ID: 25617729
[TBL] [Abstract][Full Text] [Related]
4. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
5. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.
Sharlow ER; Giridhar KV; LaValle CR; Chen J; Leimgruber S; Barrett R; Bravo-Altamirano K; Wipf P; Lazo JS; Wang QJ
J Biol Chem; 2008 Nov; 283(48):33516-26. PubMed ID: 18829454
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
[TBL] [Abstract][Full Text] [Related]
7. Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling.
Daniels A; van Bilsen M; Janssen BJ; Brouns AE; Cleutjens JP; Roemen TH; Schaart G; van der Velden J; van der Vusse GJ; van Nieuwenhoven FA
Acta Physiol (Oxf); 2010 Sep; 200(1):11-22. PubMed ID: 20175764
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein kinase D by CID755673 promotes maintenance of the pluripotency of embryonic stem cells.
Zhu Z; Zhang Y; Wang X; Wang X; Ye SD
Development; 2020 Aug; 147(16):. PubMed ID: 32747433
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.
Connelly KA; Kelly DJ; Zhang Y; Prior DL; Advani A; Cox AJ; Thai K; Krum H; Gilbert RE
Circ Heart Fail; 2009 Mar; 2(2):129-37. PubMed ID: 19808328
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
[TBL] [Abstract][Full Text] [Related]
12. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
13. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of desacyl ghrelin on diabetic cardiomyopathy.
Pei XM; Yung BY; Yip SP; Chan LW; Wong CS; Ying M; Siu PM
Acta Diabetol; 2015 Apr; 52(2):293-306. PubMed ID: 25192951
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
[TBL] [Abstract][Full Text] [Related]
17. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
19. Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.
Daltro PS; Alves PS; Castro MF; Azevedo CM; Vasconcelos JF; Allahdadi KJ; de Freitas LA; de Freitas Souza BS; Dos Santos RR; Soares MB; Macambira SG
BMC Cardiovasc Disord; 2015 Dec; 15():162. PubMed ID: 26631050
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.
Dludla PV; Essop MF; Gabuza KB; Muller CJF; Louw J; Johnson R
Heart Vessels; 2017 Aug; 32(8):1025-1031. PubMed ID: 28393273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
